EU regulators come down on repackager they say faked data

European regulators have pulled the authorization of a Danish pharma repackager they say was faking expiration dates.

European regulators have come down on a Danish pharma repackager that they say tried to hide violations from inspectors.

According to a report on the European Medicines website, the Danish Medicines Agency partially suspended the manufacturing authority of EuroPharma after finding serious breaches of compliance with GMP during an inspection in December.

Inspectors said among other problems EuroPharma falsified the expiration dates on products and sold products from contractors whose sites had never been audited for compliance.


The 13th Annual Digital Pharma East

Digital Pharma East returns to the Pennsylvania Convention Center September 17–20, bringing together over 1000 attendees from biotech and pharma, to better understand how to present business plans, justify budget and innovation, and de-risk proposals getting shut down — essentially, understand how they can return to the office and become champions for their internal digital needs. Join us and save 15% on standard rates when you register with Discount Code DPE19Fierce.

The regulator has already recalled those products it considers affected by a quality defect, like false labeling. It has pulled the company’s manufacturing authorization, saying it will not be allowed to buy or repackage products from EU markets until it can be verified the company it meeting cGMP regulations.

After about 9 months in which the European Medicines Agency was very busy classifying pharma plant inspections, activity appears to have slowed following the Brexit vote by the U,K. to leave the European Union. The EMA is headquartered in London but with the U.K. stepping away from the EU, it is expected to be moved to another country, many of which are anxious to have it. Denmark, is among many that are lobbying to get the prestigious EU agency.

Suggested Articles

Novartis' AveXis will use Catalent for some manufacturing of its newly approved gene therapy Zolgensma and more manufacturing news of note.

Pharmacy chain Rite Aid has partnered with Google to have their drug recycling stations easily searchable on Google Maps. 

Precision BioSciences says it will have a manufacturing facility for its off-the-shelf CAR-T therapies up and running in the fourth quarter.